Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
reviparin
Description:
A low-molecular-weight heparin anticoagulant used to prevent or treat thromboembolic events.
Primary topic:
Venous Thromboembolism Diagnosis and Management (37%)
Related topics:
Venous Thromboembolism Diagnosis and Management (37%),
Acute Myocardial Infarction Research (12%),
Blood Coagulation and Thrombosis Mechanisms (10%),
Coronary Interventions and Diagnostics (9%)
Wikidata ID:
wiki/Q7318417
OpenAlex ID:
keywords/reviparin
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
2000
·
James D. Douketis
, Gary A. Foster
, et al.
·
Archives of Internal Medicine
·
278
Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization
2002
·
Michael R. Lassen
, Lars C. Borris
, et al.
·
New England Journal of Medicine
·
220
PDF
Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis
2001
·
Hans Klaus Breddin
, Viola Hach-Wunderle
, et al.
·
New England Journal of Medicine
·
203
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation
2005
·
The CREATE Trial Group Investigators*
·
JAMA
·
162
PDF
Comparative Pharmacokinetics of LMWHs
2000
·
Meyer M. Samama
, Grigoris T. Gerotziafas
·
Seminars in Thrombosis and Hemostasis
·
156
Prevention of venous thromboembolism after knee arthroscopy with low–molecular weight heparin (Reviparin): Results of a randomized controlled trial
2001
·
Thomas Wirth
, Berthold Schneider
, et al.
·
Arthroscopy The Journal of Arthroscopic and Related Surgery
·
147
Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin
2002
·
Edelgard Lindhoff‐Last
, Roumen Nakov
, et al.
·
British Journal of Haematology
·
143
PDF
Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)
1996
·
Karl R. Karsch
, Melitta B. Preisack
, et al.
·
Journal of the American College of Cardiology
·
128
PDF
Extended Venous Thromboembolism Prophylaxis After Total Hip Replacement A Comparison of Low-Molecular-Weight Heparin With Oral Anticoagulant
2002
·
Charles Marc Samama
, Muriel Vray
, et al.
·
Archives of Internal Medicine
·
126
Low molecular weight heparins and their clinical applications
2019
·
Cui Hao
, Mojian Sun
, et al.
·
Progress in molecular biology and translational science
·
113
Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients
2000
·
Mark A Crowther
, Karen Spitzer
, et al.
·
Thrombosis Research
·
73
N-sulfonato-N,O-carboxymethylchitosan: A novel polymeric absorption enhancer for the oral delivery of macromolecules
2006
·
M. Thanou
, S. Henderson
, et al.
·
Journal of Controlled Release
·
67
Low molecular weight heparins: are they interchangeable? No
2003
·
G.G. Nenci
·
Journal of Thrombosis and Haemostasis
·
55
Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction
2004
·
Salim Yusuf
, Shamir R. Mehta
, et al.
·
American Heart Journal
·
49
PDF
Local drug delivery: Impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall
1999
·
Andreas Baumbach
, Christian Herdeg
, et al.
·
Catheterization and Cardiovascular Interventions
·
49
Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery
1998
·
A. Plan??s
, N. Vochelle
, et al.
·
Blood Coagulation & Fibrinolysis
·
49
Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis
2002
·
Vijay V. Kakkar
, Debra A. Hoppenstead
, et al.
·
Blood
·
43
PDF
Clinical Trials Update from the American Heart Association Meeting: ACORN-CSD, Primary Care Trial of Chronic Disease Management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, Vitamin E Meta-Analysis, ESCAPE, CARP, and SCD-HeFT Cost-Effectiveness Study
2004
·
Rhidian J. Shelton
, Periaswamy Velavan
, et al.
·
European Journal of Heart Failure
·
41
PDF
Thromboembolieprophylaxe bei minimal-invasiven Eingriffen und kurzstationärer Behandlung Ergebnisse einer multicentrischen, prospektiven, randomisierten, kontrollierten Studie mit einem niedermolekularen Heparin
1997
·
I. Baca
, B. Schneider
, et al.
·
Der Chirurg
·
39
Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys
2007
·
Uwe Gottmann
, Astrid Mueller-Falcke
, et al.
·
Transplant International
·
31
Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy
2003
·
Matthias Pross
, Hans Lippert
, et al.
·
Thrombosis Research
·
30
Crossreactivity Studies between Sera of Patients with Heparin Associated Thrombocytopenia and a New Low Molecular Weight Heparin, Reviparin
1994
·
A Greinacher
, M Feigl
, et al.
·
Thrombosis and Haemostasis
·
30
Are the pharmacokinetic parameters of low molecular weight heparins predictive of their clinical efficacy?
1996
·
Konrad Andrassy
, Volker Eschenfelder
·
Thrombosis Research
·
28
Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
2001
·
S Momi
, M Nasimi
, et al.
·
PubMed
·
25
Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteers.
1995
·
M Azizi
, C Veyssier-Belot
, et al.
·
PubMed
·
24
Show more works
View as search
Works count:
116
Citation count:
2,630
Year
Topic
Type